 | • レポートコード：QYR2104Z2543 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ゲノムバイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（タンパク質マーカー、核酸マーカー、その他）、用途別市場規模（病院、診断・研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ゲノムバイオマーカーの市場動向 ・企業の競争状況、市場シェア ・ゲノムバイオマーカーの種類別市場規模（タンパク質マーカー、核酸マーカー、その他） ・ゲノムバイオマーカーの用途別市場規模（病院、診断・研究所） ・ゲノムバイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・ゲノムバイオマーカーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ゲノムバイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ゲノムバイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・ゲノムバイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bio-Rad、Beckman Coulter、Myriad Genetics、Thermo Fisher Scientific、Roche、QIAGEN、Epigenomics、Almac、Pfizer、Human Longevity、ValiRx、Personalis、Eagle Genomics、Empire Genomics、Agilent、Illumina） ・結論 |
Market Analysis and Insights: Global Genomic Biomarker Market
The global Genomic Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genomic Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genomic Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genomic Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genomic Biomarker market.
Global Genomic Biomarker Scope and Market Size
Genomic Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genomic Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Protein Marker
Nucleic Acid Marker
Other
Segment by Application
Hospitals
Diagnostic and research laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Thermo Fisher Scientific
Roche
Personalis
Eagle Genomics
Empire Genomics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Protein Marker
1.2.3 Nucleic Acid Marker
1.2.4 Other
1.3 Market by Application
1.3.1 Global Genomic Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic and research laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genomic Biomarker Market Perspective (2016-2027)
2.2 Genomic Biomarker Growth Trends by Regions
2.2.1 Genomic Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Genomic Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Genomic Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Genomic Biomarker Industry Dynamic
2.3.1 Genomic Biomarker Market Trends
2.3.2 Genomic Biomarker Market Drivers
2.3.3 Genomic Biomarker Market Challenges
2.3.4 Genomic Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic Biomarker Players by Revenue
3.1.1 Global Top Genomic Biomarker Players by Revenue (2016-2021)
3.1.2 Global Genomic Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Genomic Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Genomic Biomarker Revenue
3.4 Global Genomic Biomarker Market Concentration Ratio
3.4.1 Global Genomic Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarker Revenue in 2020
3.5 Genomic Biomarker Key Players Head office and Area Served
3.6 Key Players Genomic Biomarker Product Solution and Service
3.7 Date of Enter into Genomic Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Biomarker Breakdown Data by Type
4.1 Global Genomic Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Genomic Biomarker Forecasted Market Size by Type (2022-2027)
5 Genomic Biomarker Breakdown Data by Application
5.1 Global Genomic Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Genomic Biomarker Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Genomic Biomarker Market Size (2016-2027)
6.2 North America Genomic Biomarker Market Size by Type
6.2.1 North America Genomic Biomarker Market Size by Type (2016-2021)
6.2.2 North America Genomic Biomarker Market Size by Type (2022-2027)
6.2.3 North America Genomic Biomarker Market Size by Type (2016-2027)
6.3 North America Genomic Biomarker Market Size by Application
6.3.1 North America Genomic Biomarker Market Size by Application (2016-2021)
6.3.2 North America Genomic Biomarker Market Size by Application (2022-2027)
6.3.3 North America Genomic Biomarker Market Size by Application (2016-2027)
6.4 North America Genomic Biomarker Market Size by Country
6.4.1 North America Genomic Biomarker Market Size by Country (2016-2021)
6.4.2 North America Genomic Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Genomic Biomarker Market Size (2016-2027)
7.2 Europe Genomic Biomarker Market Size by Type
7.2.1 Europe Genomic Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Genomic Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Genomic Biomarker Market Size by Type (2016-2027)
7.3 Europe Genomic Biomarker Market Size by Application
7.3.1 Europe Genomic Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Genomic Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Genomic Biomarker Market Size by Application (2016-2027)
7.4 Europe Genomic Biomarker Market Size by Country
7.4.1 Europe Genomic Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Genomic Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Genomic Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Genomic Biomarker Market Size by Type
8.2.1 Asia-Pacific Genomic Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Genomic Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Genomic Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Genomic Biomarker Market Size by Application
8.3.1 Asia-Pacific Genomic Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Genomic Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Genomic Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Genomic Biomarker Market Size by Region
8.4.1 Asia-Pacific Genomic Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Genomic Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Genomic Biomarker Market Size (2016-2027)
9.2 Latin America Genomic Biomarker Market Size by Type
9.2.1 Latin America Genomic Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Genomic Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Genomic Biomarker Market Size by Type (2016-2027)
9.3 Latin America Genomic Biomarker Market Size by Application
9.3.1 Latin America Genomic Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Genomic Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Genomic Biomarker Market Size by Application (2016-2027)
9.4 Latin America Genomic Biomarker Market Size by Country
9.4.1 Latin America Genomic Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Genomic Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Genomic Biomarker Market Size by Type
10.2.1 Middle East & Africa Genomic Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Genomic Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Genomic Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Genomic Biomarker Market Size by Application
10.3.1 Middle East & Africa Genomic Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Genomic Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Genomic Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Genomic Biomarker Market Size by Country
10.4.1 Middle East & Africa Genomic Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Genomic Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Details
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Genomic Biomarker Introduction
11.1.4 Bio-Rad Revenue in Genomic Biomarker Business (2016-2021)
11.1.5 Bio-Rad Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Genomic Biomarker Introduction
11.2.4 Beckman Coulter Revenue in Genomic Biomarker Business (2016-2021)
11.2.5 Beckman Coulter Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Details
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Genomic Biomarker Introduction
11.3.4 Myriad Genetics Revenue in Genomic Biomarker Business (2016-2021)
11.3.5 Myriad Genetics Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Genomic Biomarker Introduction
11.4.4 Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Genomic Biomarker Introduction
11.5.4 Roche Revenue in Genomic Biomarker Business (2016-2021)
11.5.5 Roche Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Genomic Biomarker Introduction
11.6.4 QIAGEN Revenue in Genomic Biomarker Business (2016-2021)
11.6.5 QIAGEN Recent Development
11.7 Epigenomics
11.7.1 Epigenomics Company Details
11.7.2 Epigenomics Business Overview
11.7.3 Epigenomics Genomic Biomarker Introduction
11.7.4 Epigenomics Revenue in Genomic Biomarker Business (2016-2021)
11.7.5 Epigenomics Recent Development
11.8 Almac
11.8.1 Almac Company Details
11.8.2 Almac Business Overview
11.8.3 Almac Genomic Biomarker Introduction
11.8.4 Almac Revenue in Genomic Biomarker Business (2016-2021)
11.8.5 Almac Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Genomic Biomarker Introduction
11.9.4 Pfizer Revenue in Genomic Biomarker Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Human Longevity
11.10.1 Human Longevity Company Details
11.10.2 Human Longevity Business Overview
11.10.3 Human Longevity Genomic Biomarker Introduction
11.10.4 Human Longevity Revenue in Genomic Biomarker Business (2016-2021)
11.10.5 Human Longevity Recent Development
11.11 ValiRx
11.11.1 ValiRx Company Details
11.11.2 ValiRx Business Overview
11.11.3 ValiRx Genomic Biomarker Introduction
11.11.4 ValiRx Revenue in Genomic Biomarker Business (2016-2021)
11.11.5 ValiRx Recent Development
11.12 Personalis
11.12.1 Personalis Company Details
11.12.2 Personalis Business Overview
11.12.3 Personalis Genomic Biomarker Introduction
11.12.4 Personalis Revenue in Genomic Biomarker Business (2016-2021)
11.12.5 Personalis Recent Development
11.13 Eagle Genomics
11.13.1 Eagle Genomics Company Details
11.13.2 Eagle Genomics Business Overview
11.13.3 Eagle Genomics Genomic Biomarker Introduction
11.13.4 Eagle Genomics Revenue in Genomic Biomarker Business (2016-2021)
11.13.5 Eagle Genomics Recent Development
11.14 Empire Genomics
11.14.1 Empire Genomics Company Details
11.14.2 Empire Genomics Business Overview
11.14.3 Empire Genomics Genomic Biomarker Introduction
11.14.4 Empire Genomics Revenue in Genomic Biomarker Business (2016-2021)
11.14.5 Empire Genomics Recent Development
11.15 Agilent
11.15.1 Agilent Company Details
11.15.2 Agilent Business Overview
11.15.3 Agilent Genomic Biomarker Introduction
11.15.4 Agilent Revenue in Genomic Biomarker Business (2016-2021)
11.15.5 Agilent Recent Development
11.16 Illumina
11.16.1 Illumina Company Details
11.16.2 Illumina Business Overview
11.16.3 Illumina Genomic Biomarker Introduction
11.16.4 Illumina Revenue in Genomic Biomarker Business (2016-2021)
11.16.5 Illumina Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Genomic Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Protein Marker
Table 3. Key Players of Nucleic Acid Marker
Table 4. Key Players of Other
Table 5. Global Genomic Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Genomic Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Genomic Biomarker Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Genomic Biomarker Market Share by Regions (2016-2021)
Table 9. Global Genomic Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Genomic Biomarker Market Share by Regions (2022-2027)
Table 11. Genomic Biomarker Market Trends
Table 12. Genomic Biomarker Market Drivers
Table 13. Genomic Biomarker Market Challenges
Table 14. Genomic Biomarker Market Restraints
Table 15. Global Genomic Biomarker Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Genomic Biomarker Market Share by Players (2016-2021)
Table 17. Global Top Genomic Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomic Biomarker as of 2020)
Table 18. Ranking of Global Top Genomic Biomarker Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Genomic Biomarker Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Genomic Biomarker Product Solution and Service
Table 22. Date of Enter into Genomic Biomarker Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genomic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Genomic Biomarker Revenue Market Share by Type (2016-2021)
Table 26. Global Genomic Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Genomic Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Genomic Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Genomic Biomarker Revenue Market Share by Application (2016-2021)
Table 30. Global Genomic Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Genomic Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Genomic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Genomic Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Genomic Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Genomic Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Genomic Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Genomic Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Genomic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Genomic Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Genomic Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Genomic Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Genomic Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Genomic Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Genomic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Genomic Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Genomic Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Genomic Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Genomic Biomarker Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Genomic Biomarker Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Genomic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Genomic Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Genomic Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Genomic Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Genomic Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Genomic Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Genomic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Genomic Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Genomic Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Genomic Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Genomic Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Genomic Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bio-Rad Company Details
Table 63. Bio-Rad Business Overview
Table 64. Bio-Rad Genomic Biomarker Product
Table 65. Bio-Rad Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 66. Bio-Rad Recent Development
Table 67. Beckman Coulter Company Details
Table 68. Beckman Coulter Business Overview
Table 69. Beckman Coulter Genomic Biomarker Product
Table 70. Beckman Coulter Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 71. Beckman Coulter Recent Development
Table 72. Myriad Genetics Company Details
Table 73. Myriad Genetics Business Overview
Table 74. Myriad Genetics Genomic Biomarker Product
Table 75. Myriad Genetics Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 76. Myriad Genetics Recent Development
Table 77. Thermo Fisher Scientific Company Details
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Genomic Biomarker Product
Table 80. Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 81. Thermo Fisher Scientific Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Genomic Biomarker Product
Table 85. Roche Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 86. Roche Recent Development
Table 87. QIAGEN Company Details
Table 88. QIAGEN Business Overview
Table 89. QIAGEN Genomic Biomarker Product
Table 90. QIAGEN Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 91. QIAGEN Recent Development
Table 92. Epigenomics Company Details
Table 93. Epigenomics Business Overview
Table 94. Epigenomics Genomic Biomarker Product
Table 95. Epigenomics Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 96. Epigenomics Recent Development
Table 97. Almac Company Details
Table 98. Almac Business Overview
Table 99. Almac Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 100. Almac Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Genomic Biomarker Product
Table 104. Pfizer Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Human Longevity Company Details
Table 107. Human Longevity Business Overview
Table 108. Human Longevity Genomic Biomarker Product
Table 109. Human Longevity Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 110. Human Longevity Recent Development
Table 111. ValiRx Company Details
Table 112. ValiRx Business Overview
Table 113. ValiRx Genomic Biomarker Product
Table 114. ValiRx Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 115. ValiRx Recent Development
Table 116. Personalis Company Details
Table 117. Personalis Business Overview
Table 118. Personalis Genomic Biomarker Product
Table 119. Personalis Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 120. Personalis Recent Development
Table 121. Eagle Genomics Company Details
Table 122. Eagle Genomics Business Overview
Table 123. Eagle Genomics Genomic Biomarker Product
Table 124. Eagle Genomics Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 125. Eagle Genomics Recent Development
Table 126. Empire Genomics Company Details
Table 127. Empire Genomics Business Overview
Table 128. Empire Genomics Genomic Biomarker Product
Table 129. Empire Genomics Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 130. Empire Genomics Recent Development
Table 131. Agilent Company Details
Table 132. Agilent Business Overview
Table 133. Agilent Genomic Biomarker Product
Table 134. Agilent Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 135. Agilent Recent Development
Table 136. Illumina Company Details
Table 137. Illumina Business Overview
Table 138. Illumina Genomic Biomarker Product
Table 139. Illumina Revenue in Genomic Biomarker Business (2016-2021) & (US$ Million)
Table 140. Illumina Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomic Biomarker Market Share by Type: 2020 VS 2027
Figure 2. Protein Marker Features
Figure 3. Nucleic Acid Marker Features
Figure 4. Other Features
Figure 5. Global Genomic Biomarker Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic and research laboratories Case Studies
Figure 8. Genomic Biomarker Report Years Considered
Figure 9. Global Genomic Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Genomic Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Genomic Biomarker Market Share by Regions: 2020 VS 2027
Figure 12. Global Genomic Biomarker Market Share by Regions (2022-2027)
Figure 13. Global Genomic Biomarker Market Share by Players in 2020
Figure 14. Global Top Genomic Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomic Biomarker as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Genomic Biomarker Revenue in 2020
Figure 16. Global Genomic Biomarker Revenue Market Share by Type (2016-2021)
Figure 17. Global Genomic Biomarker Revenue Market Share by Type (2022-2027)
Figure 18. North America Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Genomic Biomarker Market Share by Type (2016-2027)
Figure 20. North America Genomic Biomarker Market Share by Application (2016-2027)
Figure 21. North America Genomic Biomarker Market Share by Country (2016-2027)
Figure 22. United States Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Genomic Biomarker Market Share by Type (2016-2027)
Figure 26. Europe Genomic Biomarker Market Share by Application (2016-2027)
Figure 27. Europe Genomic Biomarker Market Share by Country (2016-2027)
Figure 28. Germany Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Genomic Biomarker Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Genomic Biomarker Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Genomic Biomarker Market Share by Region (2016-2027)
Figure 38. China Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Genomic Biomarker Market Share by Type (2016-2027)
Figure 46. Latin America Genomic Biomarker Market Share by Application (2016-2027)
Figure 47. Latin America Genomic Biomarker Market Share by Country (2016-2027)
Figure 48. Mexico Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Genomic Biomarker Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Genomic Biomarker Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Genomic Biomarker Market Share by Country (2016-2027)
Figure 54. Turkey Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Genomic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bio-Rad Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 58. Beckman Coulter Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 59. Myriad Genetics Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 62. QIAGEN Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 63. Epigenomics Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 64. Almac Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 66. Human Longevity Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 67. ValiRx Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 68. Personalis Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 69. Eagle Genomics Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 70. Empire Genomics Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 71. Agilent Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 72. Illumina Revenue Growth Rate in Genomic Biomarker Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のメタボロミクスバイオマーカー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Metabolomics Biomarker Market The global Metabolomics Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…- 世界の診断バイオマーカー市場規模・現状・予測（2021年-2027年） Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various pur…
- 世界のバイオマーカー市場規模・現状・予測（2021年-2027年） Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic inter…
- 世界のボーカルバイオマーカー市場規模・現状・予測（2021年-2027年） Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known…
- 世界のバイオマーカー検査市場規模・現状・予測（2021年-2027年） Most healthcare experts use analysis assessments to make clear and aid their scientific choice making. Steadily over latest years, the analytic manner has turned out to be more potent by means of the need to preselect sufferers in mild of medicines and licenses. This flow has come to through various…